A Clinical Trial Assessing Safety and Efficacy of BZL101 for Metastatic Breast Cancer

Clinical trial NCT00907959 · UNKNOWN

Trial details

NCT number: NCT00907959
Sponsor: Bionovo
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2012-01-01
Primary completion: 2015-01-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.